Pharmena S.A. (PHR) — Working Capital to Net Assets Ratio
Pharmena S.A. (PHR) has a Working Capital to Net Assets ratio of 85.4% as of September 2025. Working capital of zł9.00 Million (current assets of zł9.72 Million minus current liabilities of zł719.00K) is measured against net assets of zł10.54 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See debt-free asset ratio of Pharmena S.A. to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Pharmena S.A. Working Capital to Net Assets (2008–2024)
This chart shows how Pharmena S.A.'s Working Capital to Net Assets ratio has evolved across 17 annual periods from 2008 to 2024. As of September 2025, the ratio stands at 85.4%, reflecting working capital of zł9.00 Million against net assets of zł10.54 Million PLN. Check Pharmena S.A. tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Pharmena S.A. (2008–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Pharmena S.A. from 2008 to 2024, covering 17 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see PHR market cap.
| Year | WC/NA Ratio | Working Capital (PLN) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 88.3% | zł10.96 Million | zł12.42 Million | zł11.88 Million | zł915.00K | ▼ -8.7 pp |
| 2023 | 97.0% | zł21.56 Million | zł22.23 Million | zł23.33 Million | zł1.77 Million | ▼ -6.1 pp |
| 2022 | 103.1% | zł-7.00 Million | zł-6.79 Million | zł9.97 Million | zł16.97 Million | ▲ +37.1 pp |
| 2021 | 66.0% | zł-3.38 Million | zł-5.12 Million | zł8.20 Million | zł11.58 Million | ▼ -759.0 pp |
| 2020 | 825.0% | zł-2.87 Million | zł-348.00K | zł8.26 Million | zł11.13 Million | ▲ +790.1 pp |
| 2019 | 34.9% | zł1.74 Million | zł5.00 Million | zł8.25 Million | zł6.51 Million | ▲ +41.2 pp |
| 2018 | -6.3% | zł-122.00K | zł1.94 Million | zł4.68 Million | zł4.81 Million | ▼ -58.6 pp |
| 2017 | 52.3% | zł1.86 Million | zł3.56 Million | zł9.27 Million | zł7.41 Million | ▼ -17.7 pp |
| 2016 | 70.1% | zł4.16 Million | zł5.94 Million | zł12.33 Million | zł8.16 Million | ▼ -9.6 pp |
| 2015 | 79.7% | zł6.91 Million | zł8.67 Million | zł13.23 Million | zł6.33 Million | ▼ -3.0 pp |
| 2014 | 82.7% | zł10.82 Million | zł13.08 Million | zł14.27 Million | zł3.45 Million | ▼ -2.8 pp |
| 2013 | 85.5% | zł15.44 Million | zł18.05 Million | zł17.84 Million | zł2.40 Million | ▲ +20.7 pp |
| 2012 | 64.8% | zł5.82 Million | zł8.98 Million | zł8.26 Million | zł2.44 Million | ▲ +28.6 pp |
| 2011 | 36.3% | zł5.97 Million | zł16.45 Million | zł7.37 Million | zł1.41 Million | ▼ -7.3 pp |
| 2010 | 43.6% | zł6.93 Million | zł15.91 Million | zł7.64 Million | zł708.32K | ▼ -26.5 pp |
| 2009 | 70.1% | zł11.32 Million | zł16.16 Million | zł12.15 Million | zł824.55K | ▼ -14.2 pp |
| 2008 | 84.2% | zł13.29 Million | zł15.78 Million | zł13.89 Million | zł599.36K | — |